Category Archives: Drug prices

To Lower Drug Costs at Home, Trump Wants Higher Prices Abroad

Source: The New York Times | May 9, 2018 WASHINGTON — President Trump, poised on Friday to unveil his strategy to lower prescription drug prices, has an idea that may not be so popular abroad: Bring down costs at home … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, Uncategorized | Leave a comment

MSF Responds to President Trump’s Speech on Drug Pricing

Source: Medecins Sans Frontieres | May 11, 2018 The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) made the following statement today in reaction to President Donald Trump’s speech on drug pricing. Trump stated that, “When foreign governments … Continue reading

Posted in Access to Medecines, Drug prices, Uncategorized | Leave a comment

Trump’s high drug pricing speech: transcript of trade relevant section

Unofficial transcript of Trump’s ‘other countries freeloading’ portion of the high drug pricing speech  Starts at about 30:30 minutes into this video “…Finally as we demand fairness for American patients at home, we will also demand fairness overseas. When foreign … Continue reading

Posted in Drug prices, Uncategorized | Leave a comment

The Irish Times view on drug prices: Big Pharma’s hostages

Source: The Irish Times | May 7, 2018 Rising prices of new medicines are having a profound impact globally and are now exceeding the capacity of even the wealthiest of countries to pay, a recent Dublin conference on drug prices … Continue reading

Posted in Drug prices, Uncategorized | Leave a comment

Canada-EU Trade Deal Will Cost Canadians Hundreds Of Millions In Extra Drug Costs: PBO It will take longer for generic drugs to reach the market under the terms of CETA.

Source: Huffpost | April 27, 2018 OTTAWA — An extension of drug patent protections in the Canada-EU free trade deal could end up costing Canadians an estimated $392 million a year, and federal coffers up to $270 million more annually, … Continue reading

Posted in Canada, CETA, Drug prices | Leave a comment

Scottish government urged to make breast cancer drug available to Scots

Source: The National | April 24, 2018 A WOMAN forced to choose between accessing a breast cancer drug and moving back to be near family in Scotland has urged Holyrood (Scottish government) to help patients. Dunise MacIver was working in London when doctors … Continue reading

Posted in Access to Medicins, Cancer, Compulsory Licensing, Diseases/Therapies, Drug prices | Leave a comment

Scottish Compulsory Licensing campaign launches today

Highlighting a new campaign aimed at the Scottish government on the price of Roche’s pertuzumab for breast cancer Dunise is a Scottish woman with breast cancer. Right now she is getting access to a drug pertuzumab (Perjeta) because she live in England.

Posted in Cancer, Drug prices, Protest&Campaigns, Uncategorized, Upcoming events | Leave a comment